FOXG1 holds the key to unlock brain disorders affecting millions, including autism, schizophrenia, brain tumors and many more.
- Learn why FOXG1 is an excellent candidate for gene therapy and biotech investment.
- Find out how FOXG1 could be a viable drug target for Autism and other disorders here.
- FOXG1 Research Group is supported by the world-renowned BLACKSWAN Foundation in Switzerland.
- We are funding leading neuroscientists and pioneering ground-breaking research on brain disorders.